Norges Bank Apellis Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

A detailed history of Norges Bank transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Norges Bank holds 2,367,224 shares of APLS stock, worth $56.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,367,224
Holding current value
$56.6 Million
% of portfolio
0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$16.36 - $23.0 $38.7 Million - $54.4 Million
2,367,224 New
2,367,224 $41 Million
Q4 2024

Feb 12, 2025
BUY
$26.18 - $35.42 $28.4 Million - $38.5 Million
1,086,243 New
1,086,243 $34.7 Million
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $41.1 Million - $64.5 Million
1,079,605 New
1,079,605 $41.4 Million
Q1 2024

May 14, 2025
BUY
$55.39 - $72.47 $55.8 Million - $73 Million
1,007,920 New
1,007,920 $59.2 Million
Q4 2023

Feb 09, 2024
BUY
$37.14 - $64.82 $35.1 Million - $61.3 Million
946,213 New
946,213 $56.6 Million
Q3 2023

Nov 13, 2024
BUY
$23.65 - $89.22 $24.9 Million - $93.9 Million
1,052,193 New
1,052,193 $40 Million
Q3 2023

Nov 13, 2023
SELL
$23.65 - $89.22 $23 Million - $86.8 Million
-972,974 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$76.68 - $93.31 $4.34 Million - $5.28 Million
-56,579 Reduced 5.24%
1,023,026 $93.2 Million
Q2 2023

Aug 14, 2023
SELL
$76.68 - $93.31 $72.5 Million - $88.3 Million
-945,880 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$46.59 - $66.96 $43.4 Million - $62.4 Million
931,510 New
931,510 $61.4 Million
Q4 2022

Feb 14, 2023
BUY
$43.24 - $61.04 $45.3 Million - $63.9 Million
1,047,454 New
1,047,454 $54.2 Million
Q3 2022

Nov 13, 2023
BUY
$44.76 - $69.66 $43.6 Million - $67.8 Million
972,974 New
972,974 $66.5 Million
Q2 2022

Aug 14, 2023
BUY
$35.07 - $59.21 $33.2 Million - $56 Million
945,880 New
945,880 $42.8 Million
Q1 2022

May 12, 2023
SELL
$35.46 - $54.12 $8.24 Million - $12.6 Million
-232,489 Reduced 22.2%
814,965 $41.4 Million
Q1 2022

May 09, 2022
SELL
$35.46 - $54.12 $22.7 Million - $34.6 Million
-640,167 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$30.74 - $49.16 $19.7 Million - $31.5 Million
640,167 New
640,167 $30.3 Million
Q3 2021

Nov 14, 2022
BUY
$31.4 - $69.84 $16 Million - $35.6 Million
510,178 New
510,178 $16.8 Million
Q3 2021

Nov 05, 2021
SELL
$31.4 - $69.84 $13.9 Million - $30.9 Million
-441,861 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$40.9 - $64.9 $18.1 Million - $28.7 Million
441,861 New
441,861 $27.9 Million
Q2 2021

Aug 10, 2021
SELL
$40.9 - $64.9 $21 Million - $33.3 Million
-513,050 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$40.8 - $57.39 $20.9 Million - $29.4 Million
513,050 New
513,050 $22 Million
Q1 2021

May 07, 2021
SELL
$40.8 - $57.39 $27 Million - $38 Million
-662,697 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$30.79 - $57.2 $20.4 Million - $37.9 Million
662,697 New
662,697 $37.9 Million
Q4 2020

Feb 10, 2021
SELL
$30.79 - $57.2 $19.8 Million - $36.8 Million
-642,791 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$25.89 - $33.65 $16.6 Million - $21.6 Million
642,791 New
642,791 $19.4 Million
Q3 2020

Nov 10, 2020
SELL
$25.89 - $33.65 $2.71 Million - $3.52 Million
-104,687 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$24.8 - $38.49 $2.6 Million - $4.03 Million
104,687 New
104,687 $3.42 Million
Q2 2020

Aug 07, 2020
SELL
$24.8 - $38.49 $9.55 Million - $14.8 Million
-385,000 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$17.91 - $44.33 $6.9 Million - $17.1 Million
385,000 New
385,000 $10.3 Million
Q2 2018

Jul 23, 2018
SELL
$19.63 - $30.0 $1.47 Million - $2.25 Million
-75,000 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$14.01 - $26.02 $1.05 Million - $1.95 Million
75,000 New
75,000 $1.66 Million
Q1 2018

May 09, 2018
SELL
$14.01 - $26.02 $1.05 Million - $1.95 Million
-75,000 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$12.71 - $21.7 $953,250 - $1.63 Million
75,000
75,000 $1.63 Million

Others Institutions Holding APLS

# of Institutions
295
Shares Held
132M
Call Options Held
2.97M
Put Options Held
623K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.63B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email